Vaginal patterns during danazol and buserelin acetate therapy for endometriosis

Structural and ultrastructural study

L. Fedele, M. Marchini, S. Bianchi, A. Baglioni, F. Zanotti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To evaluate histologic and ultrastructural changes of the vaginal mucosa in patients given buserelin acetate or danazol treatment for endometriosis. Design: Controlled clinical study. Setting: Infertility clinic of an academic unit. Patients: Infertile women with endometriosis randomized to receive buserelin acetate or danazol and undergoing vaginal biopsies during treatment were selected. Interventions: Buserelin acetate was administered IN 400 μg three times per day and danazol orally 600 mg/d. Vaginal biopsies were performed baseline and at 3 and 6 months of treatment, and specimens were examined by light microscopy and scanning electron microscopy. 17β-Estradiol and P levels were determined in each patient at the time of each biopsy. Main Outcome Measure: Structural and ultrastructural patterns of vaginal mucosa after 3 and 6 months of treatment. Results: Buserelin acetate treatment induced early, marked hypotrophy of the vaginal mucosa with aspects typical of the menopause. The modifications caused by danazol occurred mainly in the intermediate layer, which was weakly hypotrophic only at the end of the treatment. Conclusion: Vaginal mucosa undergoes constant and well defined modifications during both buserelin acetate and danazol treatment for endometriosis. The modifications are compatible with the biological effects of the drugs.

Original languageEnglish
Pages (from-to)1191-1195
Number of pages5
JournalFertility and Sterility
Volume59
Issue number6
Publication statusPublished - 1993

Fingerprint

Buserelin
Danazol
Endometriosis
Mucous Membrane
Biopsy
Therapeutics
Menopause
Electron Scanning Microscopy
Infertility
Microscopy
Estradiol
Outcome Assessment (Health Care)
Light

Keywords

  • buserelin acetate
  • danazol
  • endometriosis
  • ultrastructure
  • Vagina

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Vaginal patterns during danazol and buserelin acetate therapy for endometriosis : Structural and ultrastructural study. / Fedele, L.; Marchini, M.; Bianchi, S.; Baglioni, A.; Zanotti, F.

In: Fertility and Sterility, Vol. 59, No. 6, 1993, p. 1191-1195.

Research output: Contribution to journalArticle

@article{77fe893fb6f84ad6b75878e3c8f14959,
title = "Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: Structural and ultrastructural study",
abstract = "Objective: To evaluate histologic and ultrastructural changes of the vaginal mucosa in patients given buserelin acetate or danazol treatment for endometriosis. Design: Controlled clinical study. Setting: Infertility clinic of an academic unit. Patients: Infertile women with endometriosis randomized to receive buserelin acetate or danazol and undergoing vaginal biopsies during treatment were selected. Interventions: Buserelin acetate was administered IN 400 μg three times per day and danazol orally 600 mg/d. Vaginal biopsies were performed baseline and at 3 and 6 months of treatment, and specimens were examined by light microscopy and scanning electron microscopy. 17β-Estradiol and P levels were determined in each patient at the time of each biopsy. Main Outcome Measure: Structural and ultrastructural patterns of vaginal mucosa after 3 and 6 months of treatment. Results: Buserelin acetate treatment induced early, marked hypotrophy of the vaginal mucosa with aspects typical of the menopause. The modifications caused by danazol occurred mainly in the intermediate layer, which was weakly hypotrophic only at the end of the treatment. Conclusion: Vaginal mucosa undergoes constant and well defined modifications during both buserelin acetate and danazol treatment for endometriosis. The modifications are compatible with the biological effects of the drugs.",
keywords = "buserelin acetate, danazol, endometriosis, ultrastructure, Vagina",
author = "L. Fedele and M. Marchini and S. Bianchi and A. Baglioni and F. Zanotti",
year = "1993",
language = "English",
volume = "59",
pages = "1191--1195",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Vaginal patterns during danazol and buserelin acetate therapy for endometriosis

T2 - Structural and ultrastructural study

AU - Fedele, L.

AU - Marchini, M.

AU - Bianchi, S.

AU - Baglioni, A.

AU - Zanotti, F.

PY - 1993

Y1 - 1993

N2 - Objective: To evaluate histologic and ultrastructural changes of the vaginal mucosa in patients given buserelin acetate or danazol treatment for endometriosis. Design: Controlled clinical study. Setting: Infertility clinic of an academic unit. Patients: Infertile women with endometriosis randomized to receive buserelin acetate or danazol and undergoing vaginal biopsies during treatment were selected. Interventions: Buserelin acetate was administered IN 400 μg three times per day and danazol orally 600 mg/d. Vaginal biopsies were performed baseline and at 3 and 6 months of treatment, and specimens were examined by light microscopy and scanning electron microscopy. 17β-Estradiol and P levels were determined in each patient at the time of each biopsy. Main Outcome Measure: Structural and ultrastructural patterns of vaginal mucosa after 3 and 6 months of treatment. Results: Buserelin acetate treatment induced early, marked hypotrophy of the vaginal mucosa with aspects typical of the menopause. The modifications caused by danazol occurred mainly in the intermediate layer, which was weakly hypotrophic only at the end of the treatment. Conclusion: Vaginal mucosa undergoes constant and well defined modifications during both buserelin acetate and danazol treatment for endometriosis. The modifications are compatible with the biological effects of the drugs.

AB - Objective: To evaluate histologic and ultrastructural changes of the vaginal mucosa in patients given buserelin acetate or danazol treatment for endometriosis. Design: Controlled clinical study. Setting: Infertility clinic of an academic unit. Patients: Infertile women with endometriosis randomized to receive buserelin acetate or danazol and undergoing vaginal biopsies during treatment were selected. Interventions: Buserelin acetate was administered IN 400 μg three times per day and danazol orally 600 mg/d. Vaginal biopsies were performed baseline and at 3 and 6 months of treatment, and specimens were examined by light microscopy and scanning electron microscopy. 17β-Estradiol and P levels were determined in each patient at the time of each biopsy. Main Outcome Measure: Structural and ultrastructural patterns of vaginal mucosa after 3 and 6 months of treatment. Results: Buserelin acetate treatment induced early, marked hypotrophy of the vaginal mucosa with aspects typical of the menopause. The modifications caused by danazol occurred mainly in the intermediate layer, which was weakly hypotrophic only at the end of the treatment. Conclusion: Vaginal mucosa undergoes constant and well defined modifications during both buserelin acetate and danazol treatment for endometriosis. The modifications are compatible with the biological effects of the drugs.

KW - buserelin acetate

KW - danazol

KW - endometriosis

KW - ultrastructure

KW - Vagina

UR - http://www.scopus.com/inward/record.url?scp=0027178501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027178501&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 1191

EP - 1195

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -